The Latin America, Middle East and Africa Opioids Market would witness market growth of 6.3% CAGR during the forecast period (2021-2027).
A depressed state that persist for at least two years is known as persistent depressive disorder (also known as dysthymia). A person with persistent depressive disorder may experience episodes of major depression as well as periods of less severe symptoms, but the symptoms must remain for at least two years in order to be labelled with persistent depressive disorder. The number of people being diagnosed with depression is growing at an accelerating rate every year. The causes of depression are thought to be ranging from genetic and biochemical to environmental and psychological factors according to many researches.
Depression can strike at any age, but it is more common in adults. Depression is now recognized as a condition that affects children and adolescents, albeit it is sometimes accompanied with irritation rather than a poor mood. The root of various chronic mood and anxiety problems in adults lies in their anxiety riddled childhood. Opioid medication is started slightly more frequently in depressed individuals than in non-depressed patients
The United Arab Emirates (UAE) has one of the fastest-growing economies in the world, which has resulted in an increase in noncommunicable diseases such as cancer. Despite screening and early detection efforts that appear to be far from goal coverage of the intended population, the number of reported cases and death have been rising in the UAE over the years. The NCBI (National Center for Biotechnology Information) presented essential aspects of a proposed national cancer control plan for the UAE in one paper. The idea is still in the works and has yet to be formally adopted. Accurate data, a reliable cancer registry, and periodic monitoring and review are all required for a comprehensive and effective management plan. The UAE's cancer management plan is being developed in accordance with WHO and EMRO guidelines, with specific aims and targets in mind. The goals are to fight cancer, limit its occurrence, control mortality, and enhance cancer patients' outcomes and quality of life. Improved public health education, prevention, early detection, fast diagnosis, treatment facilitation, continuity of care, performance evaluation, workforce training, and research are also priorities.
The Brazil market dominated the LAMEA Opioids Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $89.4 million by 2027. The Argentina market is estimated to grow at a CAGR of 6.9% during (2021 - 2027). Additionally, The UAE market would display a CAGR of 6% during (2021 - 2027).
Based on Application, the market is segmented into Pain Management, Cough Treatment and Diarrhea Treatment. Based on Product Type, the market is segmented into Methadone, Oxycodone, Hydrocodone, Fentanyl, Codeine, Morphine and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Opioids Market is Predict to reach $5.4 Billion by 2027, at a CAGR of 3.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Endo International PLC, Mallinckrodt PLC, Sanofi S.A., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., and Purdue Pharma L.P.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Pain Management
- Cough Treatment and
- Diarrhea Treatment
By Product Type
- Methadone
- Oxycodone
- Hydrocodone
- Fentanyl
- Codeine
- Morphine and
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Johnson & Johnson
- AstraZeneca PLC
- Boehringer Ingelheim International GmbH
- Endo International PLC
- Mallinckrodt PLC
- Sanofi S.A.
- Pfizer, Inc.
- Teva Pharmaceuticals Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Purdue Pharma L.P.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Opioids Market, by Application
1.4.2 LAMEA Opioids Market, by Product Type
1.4.3 LAMEA Opioids Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Opioids Market by Application
3.1 LAMEA Pain Management Market by Country
3.2 LAMEA Cough Treatment Market by Country
3.3 LAMEA Diarrhea Treatment Market by Country
Chapter 4. LAMEA Opioids Market by Product Type
4.1 LAMEA Methadone Market by Country
4.2 LAMEA Oxycodone Market by Country
4.3 LAMEA Hydrocodone Market by Country
4.4 LAMEA Fentanyl Market by Country
4.5 LAMEA Codeine Market by Country
4.6 LAMEA Morphine Market by Country
4.7 LAMEA Other Product Type Market by Country
Chapter 5. LAMEA Opioids Market by Country
5.1 Brazil Opioids Market
5.1.1 Brazil Opioids Market by Application
5.1.2 Brazil Opioids Market by Product Type
5.2 Argentina Opioids Market
5.2.1 Argentina Opioids Market by Application
5.2.2 Argentina Opioids Market by Product Type
5.3 UAE Opioids Market
5.3.1 UAE Opioids Market by Application
5.3.2 UAE Opioids Market by Product Type
5.4 Saudi Arabia Opioids Market
5.4.1 Saudi Arabia Opioids Market by Application
5.4.2 Saudi Arabia Opioids Market by Product Type
5.5 South Africa Opioids Market
5.5.1 South Africa Opioids Market by Application
5.5.2 South Africa Opioids Market by Product Type
5.6 Nigeria Opioids Market
5.6.1 Nigeria Opioids Market by Application
5.6.2 Nigeria Opioids Market by Product Type
5.7 Rest of LAMEA Opioids Market
5.7.1 Rest of LAMEA Opioids Market by Application
5.7.2 Rest of LAMEA Opioids Market by Product Type
Chapter 6. Company Profiles
6.1 Johnson and Johnson
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental &Regional Analysis
6.1.4 Research & Development Expenses
6.2 AstraZeneca PLC
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.3 Boehringer Ingelheim International Gmbh
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional & Segmental Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Approvals and Trials:
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expenses
6.5 Mallinckrodt PLC
6.5.1 Company Overview
6.5.1 Financial Analysis
6.5.2 Segmental and Regional Analysis
6.5.3 Research & Development Expense
6.6 Sanofi S.A.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Acquisition and Mergers:
6.7 Pfizer, Inc.
6.7.1 Company Overview
6.7.1 Financial Analysis
6.7.2 Regional Analysis
6.7.3 Research & Development Expense
6.7.4 Recent strategies and developments:
6.7.4.1 Approvals and Trials:
6.8 Teva Pharmaceutical Industries Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expenses
6.8.5 Recent strategies and developments:
6.8.5.1 Product Launches and Product Expansions:
6.8.5.2 Approvals and Trials:
6.9 Sun Pharmaceutical Industries Ltd.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.10. Purdue Pharma L.P.
6.10.1 Company Overview
TABLE 1 LAMEA Opioids Market, 2017 - 2020, USD Million
TABLE 2 LAMEA Opioids Market, 2021 - 2027, USD Million
TABLE 3 LAMEA Opioids Market by Application, 2017 - 2020, USD Million
TABLE 4 LAMEA Opioids Market by Application, 2021 - 2027, USD Million
TABLE 5 LAMEA Pain Management Market by Country, 2017 - 2020, USD Million
TABLE 6 LAMEA Pain Management Market by Country, 2021 - 2027, USD Million
TABLE 7 LAMEA Cough Treatment Market by Country, 2017 - 2020, USD Million
TABLE 8 LAMEA Cough Treatment Market by Country, 2021 - 2027, USD Million
TABLE 9 LAMEA Diarrhea Treatment Market by Country, 2017 - 2020, USD Million
TABLE 10 LAMEA Diarrhea Treatment Market by Country, 2021 - 2027, USD Million
TABLE 11 LAMEA Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 12 LAMEA Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 13 LAMEA Methadone Market by Country, 2017 - 2020, USD Million
TABLE 14 LAMEA Methadone Market by Country, 2021 - 2027, USD Million
TABLE 15 LAMEA Oxycodone Market by Country, 2017 - 2020, USD Million
TABLE 16 LAMEA Oxycodone Market by Country, 2021 - 2027, USD Million
TABLE 17 LAMEA Hydrocodone Market by Country, 2017 - 2020, USD Million
TABLE 18 LAMEA Hydrocodone Market by Country, 2021 - 2027, USD Million
TABLE 19 LAMEA Fentanyl Market by Country, 2017 - 2020, USD Million
TABLE 20 LAMEA Fentanyl Market by Country, 2021 - 2027, USD Million
TABLE 21 LAMEA Codeine Market by Country, 2017 - 2020, USD Million
TABLE 22 LAMEA Codeine Market by Country, 2021 - 2027, USD Million
TABLE 23 LAMEA Morphine Market by Country, 2017 - 2020, USD Million
TABLE 24 LAMEA Morphine Market by Country, 2021 - 2027, USD Million
TABLE 25 LAMEA Other Product Type Market by Country, 2017 - 2020, USD Million
TABLE 26 LAMEA Other Product Type Market by Country, 2021 - 2027, USD Million
TABLE 27 LAMEA Opioids Market by Country, 2017 - 2020, USD Million
TABLE 28 LAMEA Opioids Market by Country, 2021 - 2027, USD Million
TABLE 29 Brazil Opioids Market, 2017 - 2020, USD Million
TABLE 30 Brazil Opioids Market, 2021 - 2027, USD Million
TABLE 31 Brazil Opioids Market by Application, 2017 - 2020, USD Million
TABLE 32 Brazil Opioids Market by Application, 2021 - 2027, USD Million
TABLE 33 Brazil Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 34 Brazil Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 35 Argentina Opioids Market, 2017 - 2020, USD Million
TABLE 36 Argentina Opioids Market, 2021 - 2027, USD Million
TABLE 37 Argentina Opioids Market by Application, 2017 - 2020, USD Million
TABLE 38 Argentina Opioids Market by Application, 2021 - 2027, USD Million
TABLE 39 Argentina Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 40 Argentina Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 41 UAE Opioids Market, 2017 - 2020, USD Million
TABLE 42 UAE Opioids Market, 2021 - 2027, USD Million
TABLE 43 UAE Opioids Market by Application, 2017 - 2020, USD Million
TABLE 44 UAE Opioids Market by Application, 2021 - 2027, USD Million
TABLE 45 UAE Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 46 UAE Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 47 Saudi Arabia Opioids Market, 2017 - 2020, USD Million
TABLE 48 Saudi Arabia Opioids Market, 2021 - 2027, USD Million
TABLE 49 Saudi Arabia Opioids Market by Application, 2017 - 2020, USD Million
TABLE 50 Saudi Arabia Opioids Market by Application, 2021 - 2027, USD Million
TABLE 51 Saudi Arabia Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 52 Saudi Arabia Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 53 South Africa Opioids Market, 2017 - 2020, USD Million
TABLE 54 South Africa Opioids Market, 2021 - 2027, USD Million
TABLE 55 South Africa Opioids Market by Application, 2017 - 2020, USD Million
TABLE 56 South Africa Opioids Market by Application, 2021 - 2027, USD Million
TABLE 57 South Africa Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 58 South Africa Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 59 Nigeria Opioids Market, 2017 - 2020, USD Million
TABLE 60 Nigeria Opioids Market, 2021 - 2027, USD Million
TABLE 61 Nigeria Opioids Market by Application, 2017 - 2020, USD Million
TABLE 62 Nigeria Opioids Market by Application, 2021 - 2027, USD Million
TABLE 63 Nigeria Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 64 Nigeria Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 65 Rest of LAMEA Opioids Market, 2017 - 2020, USD Million
TABLE 66 Rest of LAMEA Opioids Market, 2021 - 2027, USD Million
TABLE 67 Rest of LAMEA Opioids Market by Application, 2017 - 2020, USD Million
TABLE 68 Rest of LAMEA Opioids Market by Application, 2021 - 2027, USD Million
TABLE 69 Rest of LAMEA Opioids Market by Product Type, 2017 - 2020, USD Million
TABLE 70 Rest of LAMEA Opioids Market by Product Type, 2021 - 2027, USD Million
TABLE 71 Key information –Johnson and Johnson
TABLE 72 Key Information – AstraZeneca PLC
TABLE 73 Key Information – Boehringer Ingelheim International GmbH
TABLE 74 key Information – Endo International PLC
TABLE 75 Key information – Mallinckrodt PLC
TABLE 76 Key Information – Sanofi S.A.
TABLE 77 Key Information – Pfizer, Inc.
TABLE 78 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 79 Key Information – Sun Pharmaceutical Industries Ltd.
TABLE 80 Key Information – Purdue Pharma L.P.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.